Survey Reveals Lifetime Cognitive Enhancer Use Prevalence Among Syrian University Students

The Numbers

The abstract does not disclose a numeric prevalence for lifetime cognitive‑enhancer (CE) use. Sample size is described only as a “convenience sample” without a specific count. Primary variables reported are binary (ever used vs. never used) and Likert‑scale responses for knowledge, attitudes, and practices, but no percentages or statistical values appear.

Context: What This Study Is

Almansour and colleagues from the Faculty of Medicine conducted a cross‑sectional survey of Syrian university students. The study aimed to fill a regional data gap by documenting self‑reported lifetime CE use, alongside participants’ awareness and attitudes toward these substances.

Data collection relied on an online questionnaire distributed through university channels. Respondents provided information on whether they had ever used a CE, how much they knew about potential benefits or risks, and their personal stance on non‑prescribed use.

What This Result Means

Identifying any proportion of students who admit to lifetime CE use suggests that the practice is present in a context where formal research is scarce. The findings add a geographic dimension to the global conversation about academic pressure and self‑medication.

From a mechanistic standpoint, the survey does not probe biochemical pathways; it merely captures self‑reported behavior, which can inform future hypothesis‑driven investigations into how stimulants or nutraceuticals might affect cognition in this population.

Study Limitations

• Absence of a reported sample size prevents assessment of statistical power or representativeness.


• Convenience sampling introduces selection bias; participants who are more engaged online may differ from the broader student body.


• Self‑reporting is vulnerable to recall bias and social desirability effects, especially for a stigmatized behavior.

Practical Application

The survey provides descriptive insight but does not establish dosage, timing, or safety parameters for any specific cognitive enhancer. It is too early to apply this information to a personal performance‑optimization protocol.

Future work would need a clearly defined cohort size, longitudinal tracking of usage patterns, and objective cognitive testing to translate these observations into actionable guidance.

Disclaimer: This article is for informational and educational purposes only. The information presented does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before modifying your diet, supplementation, or exercise routines. The scientific studies cited reflect the state of knowledge at their publication date and may be subject to revision.